Comparison of drug delivery from spacers using a standard in vitro and an ex vivo method

T. Annese, K. Looi, G. Hall, S. Devadason (Perth, WA, Australia)

Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Session: Recent advances in the treatment and pathogenesis of asthma
Session type: Thematic Poster Session
Number: 3631
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Annese, K. Looi, G. Hall, S. Devadason (Perth, WA, Australia). Comparison of drug delivery from spacers using a standard in vitro and an ex vivo method. Eur Respir J 2008; 32: Suppl. 52, 3631

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Modeling in vitro, ex vivo or in vivo?
Source: Research Seminar 2013 - Optimising models for human lung diseases and drug development
Year: 2013


Non-viral and viral gene transfer in ex vivo and in vivo lung models
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009

Development of in vitro assays to predict fibrogenesis and replace animal testing
Source: Eur Respir J 2006; 28: Suppl. 50, 521s
Year: 2006

In vitro and in vivo studies of nanoparticles and the lung
Source: International Congress 2014 – Nanomaterials and respiratory health
Year: 2014



In vivo and in vitro performance of novel high output rate nebulizer
Source: Eur Respir J 2006; 28: Suppl. 50, 733s
Year: 2006

Evaluation of delivered dose and treatment time of several mesh nebulizers under in vitro simulated use
Source: International Congress 2017 – Inhalers and their use
Year: 2017

Assessment of two different methods of bronchodilators delivery during noninvasive ventilation. Experimental in vivo approach
Source: Eur Respir J 2004; 24: Suppl. 48, 315s
Year: 2004

Scar-in-a-Jar, an in vitro screening tool for antifibrotics
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018


Anti-oxidative and anti-inflammatory effects of Xanthorrhizol on aeroallergens-induced biological responses in vitro and ex vivo
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019


An in vivo comparison of two lung function systems
Source: Eur Respir J 2005; 26: Suppl. 49, 177s
Year: 2005

A phenotypic cell-based extracellular matrix deposition assay for target validation and drug discovery
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017

In vitro generation and culture of human dendritic cells experimental model
Source: Annual Congress 2007 - Inflammatory cell biology
Year: 2007


Comparison of two in vitro IFN-γ assays for detection of latent tuberculosis infection
Source: Eur Respir J 2006; 28: Suppl. 50, 343s
Year: 2006

Assessment of pulmonary drug delivery in ex vivo mouse lungs using quantitative 3D fluorescence imaging
Source: International Congress 2014 – From lung imaging research to clinical use
Year: 2014

Comparison of rapid in-house methods for drug susceptibility testing of mycobacterium tuberculosis with gold standards
Source: Annual Congress 2007 - Research perspectives: diagnosis and treatment of tuberculosis
Year: 2007


Validation of monodisperse corticosteroid aerosols for in-vivo delivery
Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement
Year: 2008


RNAscope in situ hybridization allows spatial estimation of free drug exposure through quantification of drug induced gene expression
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Year: 2019

Pro-fibrotic biomarkers in ex vivo lung tissue slices: A species comparison
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017